Amicus Therapeutics, Inc. (FOLD) Announces Full-Year 2013 Financial Results And Corporate Updates
3/4/2014 9:35:09 AM
CRANBURY, N.J., March 3, 2014 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of therapies for rare and orphan diseases, today announced financial results for the full-year ended December 31, 2013. The Company also provided program updates and reiterated full-year 2014 operating expense guidance.
Help employers find you! Check out all the jobs and post your resume.
comments powered by